753
Participants
Start Date
October 31, 2012
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2015
EVP-6124
Arms 1, 2
Placebo
Arm 3
Tucson
Anaheim
Bellflower
Costa Mesa
Culver City
Downey
Escondido
Los Angeles
Oceanside
Orange
San Diego
Torrance
Lauderhill
Miami
North Miami
Orange City
Atlanta
Chicago
Wichita
Shreveport
Minneapolis
Flowood
Creve Coeur
O'Fallon
St Louis
Omaha
Marlton
Albuquerque
Cedarhurst
New York
Charlotte
Durham
Cleveland
Oklahoma City
Conshohocken
Norristown
Philadelphia
Dallas
La Plata
Caba
Córdoba
Mendoza
Melbourne
Rio de Janeiro
Itapira
São Paulo
Calgary
Penticton
Chatham
Kingston
Montreal
Achim
Berlin
Düsseldorf
Freiburg im Breisgau
Leipzig
Mittweida
München
Regebsburg
Regensburg
Stralsund
Wiesbaden
México
Guadalajara
Monterrey
Bialystok
Gdansk
Lodz
Lublin
Torun
Tuszyn
Warsaw
Talagi
Moscow
Saint Petersburg
Stavropol
Belgrade
Kragujevac
Niš
Novi Kneževac
Singapore
Barcelona
Mataró
Salamanca
Zamora
Alcorcón
Coslada
Madrid
Vigo
Donetsk
Ivano-Frankivsk
Kharkiv
Kyiv
Luhansk
Lead Sponsor
Collaborators (2)
Syneos Health
OTHER
NeuroCog Trials, Inc.
INDUSTRY
FORUM Pharmaceuticals Inc
INDUSTRY